Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2025-04-16 00:00:00 ET · period of report 2025-04-16 · accession 0000950170-25-054886 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-16 | 2025-04-16 | PHAT | Schroeder Theodore R | Dir | A - Grant | $0.00 | +21.0K | 21.0K | New | $0 |
| D | 2025-04-16 | 2025-04-16 | PHAT | Schroeder Theodore R | Dir | A - Grant | $0.00 | +35.0K | 35.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-16 | A | A | 21,000 | $0.00 | 21,000 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted on April 16, 2025. One-third (1/3) of the total number of RSUs granted vest on April 16, 2026, and will vest in substantially equal quarterly installments over the twenty-four (24) months thereafter, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates. Each RSU represents a contingent right to receive one share of common stock of the Issuer. |
| 2 | Derivative | Common Stock (Right to Buy) | 2025-04-16 | A | A | 35,000 | $0.00 | 35,000 | D | $4.23 · — to 2035-04-15 | 35,000 Common Stock | (F2) The stock option will vest with respect to one-third (1/3) of the shares of common stock on April 16, 2026, and will vest in substantially equal quarterly installments over the twenty-four (24) months thereafter, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates. |